Comparison 7. Oral gentamicin versus nalidixic acid.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Diarrhoea at follow up	1	79	Risk Ratio (M‐H, Fixed, 95% CI)	1.71 [0.98, 2.97]
2 Fever at follow up	1	79	Risk Ratio (M‐H, Fixed, 95% CI)	2.37 [1.11, 5.07]
3 Bacteriological relapse	1	79	Risk Ratio (M‐H, Fixed, 95% CI)	1.95 [0.64, 5.95]
4 Bacteriological failure	1	79	Risk Ratio (M‐H, Fixed, 95% CI)	2.1 [1.29, 3.42]